TransCanna Holdings Inc.

OTC: TCNAF · Healthcare · Drug Manufacturers - Specialty & Generic

Canadian filerHQ West Vancouver, BCReports USD

#736 of 1,394 Healthcare companies by revenuebottom-quartile growth

EA Score

——

FH —DQ —GM —SS 29

v0.1 · 5/100 weight · pillars only

↑ Altman-Z, Piotroski F · ↓ return on equity, market scale

Methodology →

Revenue TTM

$3.1M

Rev growth YoY (TTM)

+89.8%

Net income (FY)

-$10.4M

Employees

Market cap

$12.0k

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Revenue$3.2M4.0M CAD2021

Net income-$10.4M-13.1M CAD2021

Operating income-$7.5M-9.4M CAD2021

Total assets$20.0M25.6M CAD2021

Liabilities$17.5M22.4M CAD2021

Equity$2.5M3.3M CAD2021

Revenue trend

FY2017 – FY2021 · USD

FY17

FY18

$180.9k

FY19

$5.2M

FY20

$3.2M

FY21

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

TransCanna Holdings Inc. booked $3.2M in FY2021 revenue, contracting 38% year over year — slower than 79% of Healthcare companies we track, at a -327.4% net margin.

Peers · Healthcare

NanoLogix, Inc.——CardioGenics Holdings Inc——Eco Science Solutions, Inc.33D HEALTHeUNIVERSE, Inc.——

Key facts

CEOJames Robert Blink

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

HeadquartersWest Vancouver, BC

ExchangeOTC: TCNAF

Employees19

IPO date2019-03-04

Latest filings

No filings loaded — no CIK (non-SEC filer).

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.